In clinical trials, patients on semaglutide 2.4 mg lost an average of about 15% of their body weight over 68 weeks
Metoclopramide carries a black-box warning for tardive dyskinesia with prolonged use and should not be continued beyond 12 weeks [6]
Yes TeleSlim can evaluate, prescribe, and support access to FDA-approved GLP-1 medications like semaglutide or tirzepatide when clinically appropriate, and the clinics virtual model helps patients leverage price tiers, pharmacy options, and payment programs to reduce costs
*Correspondence: Tongzhi Wu [email protected] This article was submitted to Cellular Endocrinology, a section of the journal Frontiers in Endocrinology Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
Even if semaglutide is present, the dosage and delivery method may be insufficient for therapeutic effect, and lack of quality control means the ingredients are unverified